From the date on which the Secretary of State issues a decision providing that an active substance is approved, as referred to in point (a) of Article 9(1), the following up-to-date information , where held by the competent authority on that active substance shall be made publicly and easily available free of charge:
where available, the ISO name and the name in the International Union of Pure and Applied Chemistry (IUPAC) nomenclature;
if applicable, the name as given in the European Inventory of Existing Commercial Chemical Substances;
the classification and labelling, including whether the active substance meets any of the criteria set out in Article 5(1);
physicochemical endpoints and data on pathways and environmental fate and behaviour;
the result of each toxicological and ecotoxicological study;
acceptable exposure level or predicted no-effect concentration established in accordance with Annex VI;
the guidance on safe use provided in accordance with Annexes II and III;
analytical methods referred to under Sections 5.2 and 5.3 of Title 1, and Section 4.2 of Title 2 of Annex II.
From the date on which a biocidal product is authorised, the following up-to-date information, where held by the competent authority, shall be made publicly and easily available free of charge—
the terms and conditions of the authorisation;
the summary of the biocidal product characteristics; and
analytical methods referred to under Sections 5.2 and 5.3 of Title 1, and Section 5.2 of Title 2 of Annex III.
From the date on which the Secretary of State issues a decision providing that an active substance is approved, as referred to in point (a) of Article 9(1), the competent authority shall, except where the data supplier submits a justification in accordance with Article 66(4) accepted as valid by the competent authority … as to why such publication is potentially harmful for its commercial interests or any other party concerned, make publicly available, free of charge, the following up-to-date information where held by the competent authority on that active substance:
if essential to classification and labelling, the degree of purity of the substance and the identity of impurities and/or additives of active substances which are known to be hazardous;
the study summaries or robust study summaries of studies submitted to support the approval of the active substance;
information, other than that listed in paragraph 1 of this Article, contained in the safety data sheet;
the trade name(s) of the substance;
the assessment report.
From the date on which a biocidal product is authorised, the competent authority shall, except where the data supplier submits a justification in accordance with Article 66(4) accepted as valid by the competent authority … as to why such publication is potentially harmful for its commercial interests or any other party concerned, make publicly available, free of charge, the following up-to date information where held by the competent authority:
study summaries, or robust study summaries, of studies submitted to support the biocidal product authorisation; and
the assessment report.